Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonism

No abstract is available for this paper.

• Publication year

  1986

• Venue

  British Journal of Pharmacology

• Publication date

  1986-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.1986.tb10228.xPMID 3742146PMCID PMC1916988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A pilot study of high-dose domperidone as an antiemetic in patients treated with cisplatin.

  1985cited by this paper
• Neuronal 5-HT receptors in the periphery.

  1984cited by this paper
• MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors

  1984cited by this paper
• Neuronal connections of the area postrema.

  1984cited by this paper
• Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.

  1984cited by this paper
• Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.

  1984cited by this paper
• Ultrastructural localization of monoamines and peptides in rat area postrema.

  1984cited by this paper
• Neuronal connections of the area postrema.

  1984cited by this paper
• Cisplatin-induced emesis in the Ferret: a new animal model.

  1982cited by this paper
• Cytotoxic-therapy-induced vomiting is mediated via enkephalin pathways.

  1982cited by this paper
• Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

  1981cited by this paper

• Prophylactic use of a combination of palonosetron hydrochloride and dexamethasone to prevent transcatheter arterial chemoembolization-induced nausea and vomiting among patients with hepatocellular carcinoma

  2026cites this paper
• Pharmacokinetics, pharmacodynamics, safety, and tolerability of dopamine-receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting

  2024influential citation
• Geriatric Emergency Medication Safety Recommendations (GEMS-Rx): Modified Delphi Development of a High-Risk Prescription List for Older Emergency Department Patients.

  2024cites this paper
• Effect of Propofol Infusion on Need for Rescue Antiemetics in Postanesthesia Care Unit After Volatile Anesthesia: A Retrospective Cohort Study

  2024cites this paper
• An assessment of the effects of neurokinin1 receptor antagonism against nausea and vomiting: Relative efficacy, sites of action and lessons for future drug development

  2023cites this paper
• The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy

  2022cites this paper
• Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes

  2021cites this paper
• Nerves, smooth muscle cells and interstitial cells in the GI tract: Molecular and cellular interactions

  2020cites this paper
• The Antiemetic Effect of Xiao-Ban-Xia-Tang Formula against Cisplatin-Induced Emesis is Mediated through Inhibition of NLRP3 Inflammasome Activation in a Rat Pica Model

  2020cites this paper
• A narrative review of tropisetron and palonosetron for the control of chemotherapy-induced nausea and vomiting.

  2019cites this paper
• Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences

  2018cites this paper
• A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research

  2018cites this paper
• Antiemetic African Medicinal Spices and Vegetables

  2017cites this paper
• The Influence of Estrogen on Sex Differences in Chemotherapy-Induced Nausea and Vomiting (CINV)

  2017cites this paper
• Building a 5-HT3A Receptor Expression Map in the Mouse Brain

  2017cites this paper
• Insights into the central pathways involved in the emetic and behavioural responses to exendin-4 in the ferret.

  2017cites this paper
• Erratum to: Synthetic and natural antioxidants attenuate cisplatin-induced vomiting

  2017cites this paper
• Synthetic and natural antioxidants attenuate cisplatin-induced vomiting

  2017cites this paper
• Metoclopramide

  2017cites this paper
• Metoclopramide : An Antiemetic in Chemotherapy Induced Nausea and Vomiting

  2017cites this paper
• Miner, Wesley: transcript of a video interview (15-Jul-2016)

  2016cites this paper
• Dose-related sex differences in the establishment of conditioned disgust (anticipatory nausea), and the effect of peripubertal and adult immune system stimulation with the endotoxin lipopolysaccharide (LPS) on learning and memory in the rat

  2016cites this paper
• The Physiology and Pharmacology of Nausea and Vomiting Induced by Anticancer Chemotherapy in Humans

  2016cites this paper
• The involvement of TRPV1 in emesis and anti-emesis

  2015cites this paper
• What are the Challenges for Cancer Nursing ?

  2015cites this paper
• Endocannabinoid Mechanisms Influencing Nausea.

  2015cites this paper
• Pharmacogenetics of chemotherapy-induced nausea and vomiting.

  2015cites this paper
• Anti-emetic mechanisms of zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates

  2015cites this paper
• Administration of olanzapine as an antiemetic agent changes glucose homeostasis in cisplatin-treated rats.

  2015cites this paper
• Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogs.

  2014cites this paper
• Molecular mechanisms of 5-HT(3) and NK(1) receptor antagonists in prevention of emesis.

  2014cites this paper
• 5-Hydroxytryptamine3 receptor antagonists and cardiac side effects

  2014cites this paper
• The Ferret in Nausea and Vomiting Research: Lessons in Translation of Basic Science to the Clinic

  2014cites this paper
• Evaluation of antiemetic effect of aqueous rhizome extract of Cynodon dactylon against all emetogenic stimuli

  2014cites this paper
• Anticipatory nausea in animal models: a review of potential novel therapeutic treatments

  2014cites this paper
• Nausea and the quest for the perfect anti-emetic.

  2014cites this paper
• Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients

  2013influential citation
• EVALUATION OF SOME SELECTED MEDICINAL PLANTS AND THEIR COMBINATIONS IN CISPLATIN INDUCED VOMITING IN VOMIT MODEL(S); BEHAVIORAL NEUROCHEMICAL CORRELATES

  2013cites this paper
• Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification

  2013cites this paper
• Mental Health Retrosight

  2013cites this paper
• Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification

  2013cites this paper
• Nausea and Vomiting

  2013cites this paper
• Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets

  2013cites this paper
• Drugs Affecting 5-HT Systems

  2013cites this paper
• Behavioural effect of standardized aqueous whole plant extract of Acanthospermum hispidum: Ethnopharmacological Justification for its use in folkloric management of malaria

  2013cites this paper
• Pharmacological Agents Affecting Emesis

  2012cites this paper
• Closing Remarks

  2012cites this paper
• Mental Health Retrosight: Final report on Phase I

  2012cites this paper
• Pharmacological mechanisms of 5-HT₃ and tachykinin NK₁ receptor antagonism to prevent chemotherapy-induced nausea and vomiting.

  2012influential citation
• 5-HT3 Receptors

  2012cites this paper
• Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

  2011cites this paper
• Regulation of nausea and vomiting by cannabinoids

  2011cites this paper
• Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT3 receptor antagonists

  2010cites this paper
• Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting

  2010cites this paper
• Reduced normogastric electrical activity associated with emesis: a telemetric study in ferrets.

  2009cites this paper
• [Treatment of tumor therapy-induced nausea and vomiting].

  2009cites this paper
• Management der Chemotherapie-induzierten Emesis: Was ist Standard nach 20 Jahren klinischer Forschung?

  2009cites this paper
• Cannabinoids and the brain

  2008cites this paper
• Antiemetics: an update and the MASCC guidelines applied in clinical practice

  2008cites this paper
• Cannabinoids in the Management of Nausea and Vomiting

  2008cites this paper
• Efficacy of a Scheduled IV Cocktail of Antiemetics for the Palliation of Nausea and Vomiting in a Hospice Population

  2008cites this paper
• Seasonal Modulation of the 8‐and 24‐Hour Rhythms of Ondansetron Tolerance in Mice

  2007cites this paper
• Anti-emetic therapy in cancer chemotherapy: current status.

  2007cites this paper
• The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer, vol. 30.

  2007cites this paper
• Treatment of nausea and vomiting: gaps in our knowledge.

  2006cites this paper
• The antiemetic drug trimethobenzamide prevents hypophagia due to acetyl salicylate, but not to 5-HT1B or 5-HT1C agonists

  2006cites this paper
• Functional roles of 5-hydroxytryptamine 3/4 receptors in neurons of rat dorsal motor nucleus of the vagus.

  2006cites this paper
• Nausea and Vomiting in the Cancer Patient

  2006cites this paper
• New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations.

  2006influential citation
• Phase I Trial and Pharmacokinetics of Trimelamol (TV^A^A^-Trihydroxymethyl-A^A^A^-trimethylmelamine)1

  2006cites this paper
• Central serotonergic control of cardiovascular reflexes.

  2005cites this paper
• Dose-finding study of oral metopimazine

  2005cites this paper
• A dose-finding study of granisetron, a novel antiemetic, in patients receiving cytostatic chemotherapy

  2005cites this paper
• Cannabinoids: effects on vomiting and nausea in animal models

  2005cites this paper
• Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal

  2005cites this paper
• 5-Hydroxytryptamine (serotonin) subtype 3 antagonists, a major step in prophylaxis and control of cytostatic and radiation-induced emesis

  2005cites this paper
• The antiemetic activity of granisetron against cytostatic-treatment-induced emesis in 10- to 13-week-old ferrets

  2005cites this paper
• A pilot study of high‐dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0–N3M0 squamous cell carcinoma of the upper aerodigestive tract

  2005cites this paper
• Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors

  2004cites this paper
• GR38032F, a 5HT3 receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting

  2004cites this paper
• A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy

  2004cites this paper
• A single-dose-finding study of the antiemetic effect and associated plasma levels of MDL 72222 in patients receiving cisplatin

  2004cites this paper
• Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation

  2004cites this paper
• A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

  2004cites this paper
• A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response

  2004cites this paper
• The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide

  2004cites this paper
• Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.

  2004cites this paper
• Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting

  2004cites this paper
• Two decades of progress in treating chemotherapy induced emesis

  2004cites this paper
• An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramidecontaining antiemetic cocktail in the prevention of cisplatin-induced emesis

  2004cites this paper
• Granisetron: is there a dose–response effect on nausea and vomiting?

  2003cites this paper
• Circadian Rhythms in Toxic Effects of the Serotonin Antagonist Ondansetron in Mice

  2003cites this paper
• Use of antipsychotic medicationin chemotherapy-induced nausea and vomiting

  2003cites this paper
• Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.

  2003cites this paper
• Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.

  2003cites this paper
• The role of behavioral conditioning in the development of nausea.

  2002cites this paper
• Differential Composition of 5-Hydroxytryptamine3Receptors Synthesized in the Rat CNS and Peripheral Nervous System

  2002cites this paper
• Nausea and emesis: evidence for a biobehavioral perspective

  2002cites this paper
• An Arterially Perfused Decerebrate Preparation of Suncus Murinus (House Musk Shrew) for the Study of Emesis and Swallowing

  2002cites this paper
• Pica in mice as a new model for the study of emesis.

  2002cites this paper